Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC Offerings

Published on November 16, 2021

Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC Offerings

Continue reading on website
Other news

Welsh, Carson, Anderson & Stowe Acquires Majority Stake in Leiters, A 503B Outsourced Pharmaceutical Compounding Industry Leader, in Partnership with Leading Health Systems

November 15, 2021
The post Welsh, Carson, Anderson & Stowe Acquires Majority Stake in Leiters, A 503B Outsourced Pharmaceutical Compounding Industry Leader, in Partnership with Leading Health Systems appeared first on Leiters.

Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC Offerings

November 16, 2021
Ncardia forms strategic partnership with Kiniciti to build GMP capabilities to support iPSC cell therapy platforms and human cell-based in vitro discovery servicesGosselies, Belgium and New York, N.Y. (Nov. 16, 2021) – Ncardia, a leader in developing stem cell-based solutions for drug discovery and cell therapy, announced that it has secured more than $60 million in capital through a strategic par